Onkos Surgical Launches GenVie Magnesium Bone Scaffold

By Julie A. Vetalice

Onkos Surgical Launches GenVie Magnesium Bone Scaffold

Onkos Surgical introduced GenVie™ Magnesium Bone Scaffold with application in complex limb salvage procedures.  GenVie is the first 510(k) cleared magnesium-based bone void filler in the orthopedic market and is available via a private label distribution agreement with Bone Solutions.

GenVie injectable, moldable bone void filler combines osteoconductive and high compression strength to support bone repair and regeneration. It is used in surgically-created osseous defects or osseous defects from traumatic injury to the bone, and has a reported healing rate of 80% at 26 weeks in a preclinical model.

GenVie complements Onkos' personalized surgical planning, 3D printed limb salvage offerings and 3D patient-specific joint sparing tools.

Product Labels: Synthetic Bone Graft